Medical
Federal Supreme Court: health insurers must reimburse medical cannabis
A landmark ruling (BGE 9C_412/2025) requires health insurers to reimburse medical cannabis therapies for clearly defined indications.
Written by CannabisClub Editorial TeamHealth editorial team: CannabisClub Health Editorial Team
Written by CannabisClub Editorial TeamHealth editorial team: CannabisClub Health Editorial Team
Key facts
- Category
- Medical
- Published
- 2026-06-05
- Updated
- 2026-06-05
- Sources
- 1
On 5 June 2026, in ruling 9C_412/2025, the Swiss Federal Supreme Court held that the mandatory basic health insurance (OKP/AOS) must cover medical cannabis in medically justified cases.
Insurers have 90 days to adapt their internal guidelines. The precedent concerned a patient with treatment-resistant spasticity in multiple sclerosis.
Sources
— Stronger together
The next step starts with us
We’re preparing the next drops. Join for free and help build the community.
More news
Pilot project · 2026-07-10
Basel Weed Care: mid-point results show falling black-market demand
Market · 2026-07-01
FOPH monitoring: Swiss cannabis market grows to CHF 630 M in 2026
Pilot project · 2026-06-24
Züri Can pilot expanded to 4,000 participants
Law & politics · 2026-05-28
Motion 20.4211: National Council backs a regulated cannabis market